GlassScriptPhysician profile
Stacey Epperson Moffitt
NPI 1447294582
$219.85
in general payments reported to CMS, 2019-2025
9 companies · $94.83 in 2025
The $94.83 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.86 · 2022: $79.13 · 2024: $33.03 · 2025: $94.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $127.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $42.95 | 2021-2024 | Pteye Parathyroid Detection System |
| Conmed Corporation | $33.38 | 2025 | Conmed Specimen Retrieval, Airseal |
| Octapharma USA, INC. | $32.97 | 2025 | Fibryga |
| Kerecis Limited | $28.48 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Becton, Dickinson and Company | $20.19 | 2022 | |
| Heron Therapeutics, INC. | $17.08 | 2022 | |
| Smith+Nephew, INC. | $16.53 | 2022 | |
| Hologic Sales and Service, LLC | $15.47 | 2024 | Trunode |
| Baxter Healthcare | $12.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Moffitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.